Anticancer Research

雜志介紹

Anticancer Research雜志介紹

《Anticancer Research》是一本以English為主的未開放獲取國際優秀期刊，中文名稱抗癌研究，本刊主要出版、報道醫學-ONCOLOGY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為1.6，最新CiteScore 指數為3.7。

本刊近期中國學者發表的論文主要有：

• Chalcone Derivatives Suppress Proliferation and Migration of Castration-resistant Prostate Cancer Cells Through FAK-mediated DNA Damage

  Author: Xiao, H. A. I. N. I. A. O.; Wu, Z. H. I. G. A. N. G.; Wang, Q. I. N. Q. U. A. N.; Zhou, C. H. A. O. F. E. N. G.; Lu, F. E. N. G.; Xiao, Y. U. N. B. E., I

• Association of Matrix Metalloproteinase-7 Genotypes With Prostate Cancer Risk

  Author: Liao, Cheng-hsi; Chang, Wen-shin; Hsu, Wei-lin; Hu, Pei-shin; Wu, Hsi-chin; Hsu, Shih-wei; Wang, Bo-ren; Yueh, Te-cheng; Chen, Chao-hsuan; Hsia, Te-chun; Huang, Wen-chin; Bau, Da-tian; Tsai, Chia-wen

• Association of Matrix Metalloproteinase-2 Genotypes With Prostate Cancer Risk

  Author: LI, Po-han; Liao, Cheng-hsi; Huang, Wen-chin; Chang, Wen-shin; Wu, Hsi-chin; Hsu, Shih-wei; Chen, Kai-yuan; Wang, Zhi-hong; Hsia, Te-chun; Bau, Da-tian; Tsai, Chia-wen

• Clinical Value of Magnetic Resonance Imaging Combined With Serum Prostate-specific Antigen, Epithelial Cadherin and Early Prostate Cancer Antigen 2 In Diagnosis of Prostate Cancer

  Author: Li, Kun; Luan, Qingxia; Zheng, Junze; Li, Ruidong; Li, Linkun; Sun, Yequan; Liu, Donghui

英文介紹

Anticancer Research雜志英文介紹

ANTICANCER RESEARCH is an independent international peer-reviewed journal devoted to the rapid publication of high quality original articles and reviews on all aspects of experimental and clinical oncology. Prompt evaluation of all submitted articles in confidence and rapid publication within 1-2 months of acceptance are guaranteed.

ANTICANCER RESEARCH was established in 1981 and is published monthly (bimonthly until the end of 2008). Each annual volume contains twelve issues and index. Each issue may be divided into three parts (A: Reviews, B: Experimental studies, and C: Clinical and Epidemiological studies).

Special issues, presenting the proceedings of meetings or groups of papers on topics of significant progress, will also be included in each volume. There is no limitation to the number of pages per issue.